Calysta will develop the production process for FeedKind protein at its Centre for Process Innovation (CPI) in Teesside, UK.
FeedKind is a new fish feed ingredient to reduce the aquaculture industry’s use of fishmeal, approved for sale in the European Union.
Originally based in California, Calysta has received a conditional award of up to £2.8m Exceptional Regional Growth Fund (eRGF) grant subject to due diligence from the UK Government.
Alan Shaw, Calysta President and CEO, said: “The eRGF grant is a major vote of confidence for us from the UK Government. After looking at potential sites around Europe, we look forward to building Calysta's first plant in Teesside.”
The eRGF will contribute to a £30m first phase investment over ten years by Calysta to develop a Market Introduction Facility to undertake R&D critical to commercialise FeedKind and develop the technology for other applications
“Teesside remains an important centre for the process industry and we are keen to capitalise on the area’s commercial attractiveness, technical skills and research and development expertise,” Mr Shaw added.
He concluded: “Our plant will not only provide a boost for the economy of North East England, but will also support the UK’s goal to become a world leader in the emerging industrial biotechnology sector by generating game changing technology in gas fermentation and synergistic applications.”
The project is expected to safeguard and create up to 39 positions in science, engineering and operations, as well as create indirect jobs benefits in construction and the supply chain.
